Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Kidney Diseases

• Publication date

  1998-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/AJKD.1998.V32.PM9669419PMID 9669419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic nephropathy and arterial hypertension

  2004cited by this paper
• Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

  1997cited by this paper
• Sodium balance in renal failure

  1997cited by this paper
• The influence of dietary salt on the antiproteinuric effect of calcium channel blockers.

  1997cited by this paper
• Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.

  1997cited by this paper
• Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.

  1997cited by this paper
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

  1997cited by this paper
• Insulin resistance and salt sensitivity. A renal hemodynamic abnormality?

  1996cited by this paper
• Salt intake and reductions in arterial pressure and proteinuria. Is there a direct link?

  1996cited by this paper
• Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

  1996cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Blood pressure and end-stage renal disease in men.

  1996cited by this paper
• Hypertension in African Americans: a paradigm of metabolic disarray.

  1996cited by this paper
• 1995 update of the working group reports on chronic renal failure and renovascular hypertension. National High Blood Pressure Education Program Working Group.

  1996cited by this paper
• Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.

  1996cited by this paper
• Will angiotensin II receptor antagonists be renoprotective in humans?

  1996cited by this paper
• Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin.

  1996cited by this paper
• Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease.

  1996cited by this paper
• Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.

  1996cited by this paper
• Effects of Sodium Intake on Albumin Excretion in Patients with Diabetic Nephropathy Treated with Long-Acting Calcium Antagonists

  1996cited by this paper
• Angiotensin-II receptor antagonists: a new class of antihypertensive agents.

  1996cited by this paper
• Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension.

  1996cited by this paper
• Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?

  1996cited by this paper
• Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group.

  1996cited by this paper
• "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.

  1995cited by this paper
• Salt intake and hypertensive renal injury in African-Americans. A therapeutic perspective.

  1995cited by this paper
• Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

  1995cited by this paper
• Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria

  1995cited by this paper
• Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors.

  1995cited by this paper
• Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.

  1995cited by this paper
• Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria.

  1995cited by this paper
• Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment.

  1995cited by this paper
• Renal function during antihypertensive treatment.

  1995cited by this paper
• Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.

  1995cited by this paper
• Early predictors of 15-year end-stage renal disease in hypertensive patients.

  1995cited by this paper
• Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model.

  1994cited by this paper
• Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.

  1994cited by this paper
• Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure

  1994cited by this paper
• Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group.

  1994cited by this paper
• Salt sensitivity in hypertension. Renal and cardiovascular implications.

  1994cited by this paper
• The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

  1994cited by this paper
• Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

  1994cited by this paper
• Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival.

  1994cited by this paper
• Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition.

  1993cited by this paper
• Impact of Arterial Blood Pressure and Albuminuria on the Progression of Diabetic Nephropathy in IDDM Patients

  1993cited by this paper
• Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis.

  1993cited by this paper
• Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.

  1993cited by this paper
• An evaluation of the renal protective effect of manidipine in the uninephrectomized spontaneously hypertensive rat.

  1993cited by this paper
• The familial risk of end-stage renal disease in African Americans.

  1993cited by this paper
• The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

  1993cited by this paper
• Essential hypertension in blacks: is it a metabolic disorder?

  1993cited by this paper
• The quantitative relationship between treated blood pressure and progression of diabetic renal disease.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

  1992cited by this paper
• Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure.

  1992cited by this paper
• The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.

  1992cited by this paper
• Renal protective effect of enalapril in diabetic nephropathy: Author's reply

  1992cited by this paper
• Long-term comparison between captopril and nifedipine in the progression of renal insufficiency.

  1992cited by this paper
• Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.

  1992cited by this paper
• Twenty-four hour blood pressure variability: clinical implications.

  1992cited by this paper
• Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis.

  1992cited by this paper
• Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys.

  1992cited by this paper
• Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.

  1991cited by this paper
• Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

  1991cited by this paper
• Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions.

  1991cited by this paper
• Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Blood pressure by 24 h ambulatory recordings in type 2 (non-insulin dependent) diabetics. Relationship to urinary albumin excretion.

  1991cited by this paper
• The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects.

  1990cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

  1990cited by this paper
• Progressive renal disease: role of race and antihypertensive medications.

  1990cited by this paper
• The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.

  1990cited by this paper
• Effect of hypertension and type II diabetes on renal function in an urban population.

  1990cited by this paper
• Progression of renal insufficiency: role of blood pressure.

  1989cited by this paper
• Renal insufficiency in treated essential hypertension.

  1989cited by this paper
• Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

  1989cited by this paper
• The progression of renal disease.

  1989cited by this paper
• Converting enzyme inhibition in chronic renal failure.

  1989cited by this paper
• Effects of antihypertensive drugs on glomerular morphology.

  1989cited by this paper
• Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

  1989cited by this paper
• Lipids and progressive renal injury.

  1989cited by this paper
• Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes

  1988cited by this paper
• Proteinuria in IgA nephropathy.

  1987cited by this paper
• Effect of antihypertensive treatment on kidney function in diabetic nephropathy.

  1987cited by this paper
• Proteinuria in hypertension.

  1987cited by this paper
• Verapamil protects against progression of experimental chronic renal failure.

  1987cited by this paper
• Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy.

  1987cited by this paper
• Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

  1986cited by this paper
• Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

  1985cited by this paper
• Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy.

  1985cited by this paper
• Natural history of hypertension in renal parenchymal disease.

  1985cited by this paper
• Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden.

  1985cited by this paper
• Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise.

  1984cited by this paper
• The prognostic significance of proteinuria: the Framingham study.

  1984cited by this paper
• Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.

  1983cited by this paper
• Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

  1983cited by this paper
• Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

  1976cited by this paper
• Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

  1972cited by this paper

• Sodium Knowledge, Beliefs, and Behaviors in Patients on Chronic Hemodialysis

  2019cites this paper
• Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease

  2016cites this paper
• Effects of Long Term Consumption of Animal Proteins in the High Calorie Diet

  2015cites this paper
• High Calorie Diet and the Human Brain

  2015cites this paper
• Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome

  2015cites this paper
• Dyslipidemias in the Pediatric Chronic Kidney Disease Patient

  2014cites this paper
• Effects of interventions in the RAAS and sodium status on classical and non-classical outcome parameters in chronic kidney disease

  2012cites this paper
• Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.

  2012cites this paper
• Hypertension in End-Stage Renal Disease

  2011cites this paper
• Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.

  2011cites this paper
• Relationship between beliefs regarding a low salt diet in chronic renal failure patients on dialysis.

  2011cites this paper
• Chronic Kidney Disease in the Primary Care Setting: Importance for Estimating Cardiovascular Disease Risk and Use of Appropriate Therapies

  2011cites this paper
• Optimizing Blood Pressure Control in Patients with Chronic Kidney Disease

  2010cites this paper
• Variables influencing adoption of practice-based guidelines in Canadian renal dietetic practice.

  2010cites this paper
• Altered dietary salt intake for preventing and treating diabetic kidney disease.

  2010cites this paper
• Studies of Depression and Illness Representations in End-Stage Renal Disease

  2010cites this paper
• Serum creatinine is an inadequate screening test for renal failure in ischemic stroke patients

  2009cites this paper
• Investigation of common Indian edible salts suitable for kidney disease by laser induced breakdown spectroscopy

  2009cites this paper
• Hypertension after renal transplantation

  2009cites this paper
• Developmental Programming of the Kidney

  2009cites this paper
• Salt: its role in chronic kidney disease.

  2008cites this paper
• Challenges in pediatric peritoneal dialysis in Turkey

  2008cites this paper
• Cardiovascular complications of pediatric chronic kidney disease

  2008cites this paper
• Mechanism of dietary salt-mediated increase in intravascular production of TGF-beta1.

  2008cites this paper
• Chapter 53 – Calcium Channel Blockers

  2008cites this paper
• Renal Granulomatoses: A Retrospective Study of 40 Cases and Review of the Literature

  2007cites this paper
• Regional differences in end-stage renal disease and amount of protein intake in Japan.

  2007cites this paper
• Acquired fanconi syndrome with osteomalacia secondary to monoclonal gammopathy of undetermined significance.

  2007cites this paper
• Is it the low-protein diet or simply the salt restriction?

  2007cites this paper
• Calcium Channels Blockers and Progression of Kidney Disease

  2007cites this paper
• Microalbuminuria en diabetes tipo 2: signo de riesgo y oportunidad terapéutica

  2007cites this paper
• 2005 Annual Report: ESRD Clinical Performance Measures Project.

  2006cites this paper
• The Impact of New Comorbidities on Nutritional Status in Continuous Ambulatory Peritoneal Dialysis Patients

  2006cites this paper
• Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrolgy Consortium study

  2006cites this paper
• Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention.

  2006cites this paper
• Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive rats.

  2005cites this paper
• Multiple risk factor intervention in chronic kidney disease: management of cardiac disease in chronic kidney disease patients.

  2005cites this paper
• Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management.

  2005cites this paper
• Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary.

  2005cites this paper
• Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report

  2005cites this paper
• Cardiovascular Morbidity and Mortality in Children with Chronic Kidney Disease in North America: Lessons from the Usrds and Naprtcs Databases

  2005cites this paper
• Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.

  2005cites this paper
• Does dietary salt increase the risk for progression of kidney disease?

  2005cites this paper
• Cardiovascular disease in children with chronic kidney disease.

  2005cites this paper
• Control of Hypertension with Captopril Affords Better Renal Protection as Compared with Irbesartan in Salt-Loaded Uremic Rats

  2005cites this paper
• Sympathetic hyperactivity in chronic renal failure: a wake-up call.

  2004cites this paper
• Biochemistry and Clinical Role of Human Cystatin C

  2004cites this paper
• Elevated arterial pressure impairs autoregulation independently of AT1 receptor activation

  2004cites this paper
• Hypertension but Not Sodium Intake Determines Progression of Renal Failure in Experimentally Uremic Rats

  2004cites this paper
• Prevenção da Progressão da Doença Renal Crônica (DRC)

  2004cites this paper
• Diabetic renal disease: from recent studies to improved clinical practice

  2004cites this paper
• Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure

  2004cites this paper
• Microalbuminuria in Type 2 Diabetics: An Important, Overlooked Cardiovascular Risk Factor

  2004cites this paper
• Impacto de los fármacos antihipertensivos sobre la enfermedad renal

  2004cites this paper
• Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

  2003cites this paper
• Effect of Combination Therapy with a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor on Renal Hypertrophy and Urinary Albumin Excretion in Diabetic Rats

  2003cites this paper
• Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat.

  2003cites this paper
• Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase.

  2003cites this paper
• THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Applying Multiple Interventions in Chronic Kidney Disease

  2003cites this paper
• Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.

  2003cites this paper
• Effects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial.

  2003cites this paper
• High Prevalence of Target Organ Damage in Young, African American Inner‐City Men With Hypertension

  2003cites this paper
• Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

  2003cites this paper
• Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.

  2003cites this paper
• Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure.

  2003cites this paper
• Emerging drugs for renal failure

  2003cites this paper
• Aristolochic Acid and ‘Chinese Herbs Nephropathy’

  2003cites this paper
• Pediatric end-stage renal disease: heart as a target.

  2002cites this paper
• Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease

  2002cites this paper
• Small Apolipoprotein(a) Size Predicts Mortality in End-Stage Renal Disease: The CHOICE Study

  2002cites this paper
• Dose response of carboplatin-induced nephrotoxicity in rats.

  2002cites this paper
• Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid?

  2002cites this paper
• Intrarenal arteriovenous fistula causing a ‘‘pseudonutcracker effect’’

  2002cites this paper
• Progressive renal and cardiovascular disease: optimal treatment strategies.

  2002cites this paper
• Evidence-Based Herbalism

  2002cites this paper
• The spectrum of long-term renal transplantation: Outcomes, complications, and clinical studies

  2002cites this paper
• Impaired renal autoregulation: implications for the genesis of hypertension and hypertension-induced renal injury.

  2001cites this paper
• Appropriate Use of Calcium Antagonists in Hypertension

  2001cites this paper
• Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

  2001cites this paper
• Diabetes and hypertension: how low should you go and with which drugs?

  2001cites this paper
• Hypertension in Patients with Type 2 Diabetes

  2001cites this paper
• Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).

  2001cites this paper
• A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease

  2001cites this paper
• Role of hypertension in the progression of chronic renal disease.

  2001influential citation
• The nutcracker syndrome: its role in the pelvic venous disorders.

  2001cites this paper
• Rationalizing the treatment of hypertension.

  2001influential citation
• The effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis

  2001influential citation
• Hypertension in patients with type 2 diabetes.

  2001cites this paper
• Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

  2001cites this paper
• The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time.

  2001cites this paper
• Treatment of Hypertensive Patients with Chronic Renal Insufficiency

  2001cites this paper
• Onset of glomerular hypertension with aging precedes injury in the spontaneously hypertensive rat.

  2000cites this paper
• Angiotensin-Converting Enzyme Inhibition: Facts and Fiction

  2000cites this paper
• Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.

  2000cites this paper
• INFLUENCE OF THE TIMING OF INITIATING ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE RATS WITH RENAL FAILURE

  2000cites this paper
• Is angiotensin II's role in fibrosis as easy as PAI(-1)?

  2000cites this paper
• Preventing renal disease progression: Is it the drug or the blood pressure reduction, or both?

  2000cites this paper
• Chronic renal insufficiency: current understandings and their implications.

  2000cites this paper
• [Symptomatic treatment of nephrotic syndrome].

  2000cites this paper
• Peritoneal dialysis adequacy and risk of death.

  2000cites this paper